Template:Butalbital/aspirin/caffeine/codeine: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 100%; background:#F8F8...") |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | ||
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Butalbital/aspirin/caffeine/codeine|{{fontcolor|#6C7B8B| | ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Butalbital/aspirin/caffeine/codeine|{{fontcolor|#6C7B8B|Butalbital/aspirin/caffeine/codeine}}]]''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule<sup>®</sup> FDA Package Insert | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule<sup>®</sup> FDA Package Insert | ||
| Line 36: | Line 36: | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule labels and packages|Labels and Packages]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule labels and packages|Labels and Packages]] | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Butalbital, aspirin, cafeine, and codeine | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov] | ||
|- | |- | ||
|} | |} | ||
Latest revision as of 00:14, 12 February 2014
| Butalbital/aspirin/caffeine/codeine |
|---|
| ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Dosage Forms and Strengths |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Butalbital, aspirin, cafeine, and codeine |
| ClinicalTrials.gov |